Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS

Clinical trial NCT07579247 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07579247
Sponsor: Shanghai Public Health Clinical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV AIDS Immune Checkpoint Inhibitors Refractory Opportunistic Infection

Start date: 2026-05-01
Primary completion: 2029-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.